<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytometry A</journal-id><journal-id journal-id-type="iso-abbrev">Cytometry A</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">CYTO</journal-id><journal-title-group><journal-title>Cytometry</journal-title></journal-title-group><issn pub-type="ppub">1552-4922</issn><issn pub-type="epub">1552-4930</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6972618</article-id><article-id pub-id-type="pmcid-ver">PMC6972618.1</article-id><article-id pub-id-type="pmcaid">6972618</article-id><article-id pub-id-type="pmcaiid">6972618</article-id><article-id pub-id-type="pmid">31633878</article-id><article-id pub-id-type="doi">10.1002/cyto.a.23907</article-id><article-id pub-id-type="publisher-id">CYTOA23907</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Omip</subject></subj-group><subj-group subj-group-type="heading"><subject>Omip</subject></subj-group></article-categories><title-group><article-title>OMIP&#8208;062: A 14&#8208;Color, 16&#8208;Antibody Panel for Immunophenotyping Human Innate Lymphoid, Myeloid and T Cells in Small Volumes of Whole Blood and Pediatric Airway Samples</article-title><alt-title alt-title-type="right-running-head">Immunophenotyping leukocytes in small volume pediatric samples</alt-title></title-group><contrib-group><contrib id="cytoa23907-cr-0001" contrib-type="author"><name name-style="western"><surname>Swieboda</surname><given-names initials="D">Dawid</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="cytoa23907-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="cytoa23907-cr-0002" contrib-type="author"><name name-style="western"><surname>Guo</surname><given-names initials="Y">Yanping</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa23907-cr-0003" contrib-type="author"><name name-style="western"><surname>Sagawe</surname><given-names initials="S">Sophie</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa23907-cr-0004" contrib-type="author"><name name-style="western"><surname>Thwaites</surname><given-names initials="RS">Ryan S.</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="cytoa23907-cr-0005" contrib-type="author"><name name-style="western"><surname>Nadel</surname><given-names initials="S">Simon</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="cytoa23907-cr-0006" contrib-type="author"><name name-style="western"><surname>Openshaw</surname><given-names initials="PJM">Peter J.M.</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="cytoa23907-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="cytoa23907-cr-0007" contrib-type="author" corresp="yes"><name name-style="western"><surname>Culley</surname><given-names initials="FJ">Fiona J.</given-names></name><xref ref-type="aff" rid="cytoa23907-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="cytoa23907-aff-0002">
<sup>2</sup>
</xref><address><email>f.culley@imperial.ac.uk</email></address></contrib></contrib-group><aff id="cytoa23907-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">National Heart and Lung Institute</named-content>
<institution>Imperial College London</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="cytoa23907-aff-0002">
<label><sup>2</sup></label>
<institution>Asthma UK Centre in Allergic Mechanisms of Asthma</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><aff id="cytoa23907-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Paediatric Intensive Care Unit</named-content>
<institution>St Mary's Hospital, Imperial College Healthcare NHS Trust</institution>
<city>London</city>
<country country="GB">UK</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>
Correspondence to: Fiona J. Culley, NHLI, Faculty of Medicine, Imperial College London, St Mary's Campus, London, W2 1PG, UK<break/>
Email: <email>f.culley@imperial.ac.uk</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>10</month><year>2019</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2019</year></pub-date><volume>95</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">350458</issue-id><issue-id pub-id-type="doi">10.1002/cyto.a.v95.12</issue-id><fpage>1231</fpage><lpage>1235</lpage><history><date date-type="received"><day>21</day><month>6</month><year>2019</year></date><date date-type="rev-recd"><day>17</day><month>9</month><year>2019</year></date><date date-type="accepted"><day>19</day><month>9</month><year>2019</year></date></history><pub-history><event event-type="pmc-release"><date><day>21</day><month>01</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>27</day><month>01</month><year>2020</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2020-01-28 00:20:30.723"><day>28</day><month>01</month><year>2020</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2019 The Authors. <italic toggle="yes">Cytometry Part A</italic> published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.</copyright-statement><license license-type="creativeCommonsBy"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CYTO-95-1231.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CYTO-95-1231.pdf"/><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>Asthma UK Centre in Allergic Mechanisms of Asthma </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000362</institution-id></institution-wrap></funding-source><award-id>AUK&#8208;BC&#8208;2015&#8208;01</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Imperial College Healthcare NHS Trust Biomedical Research Centre </institution><institution-id institution-id-type="open-funder-registry">10.13039/501100000762</institution-id></institution-wrap></funding-source><award-id>RDA02 and P82570</award-id></award-group><award-group id="funding-0003"><funding-source>The Wellcome Trust</funding-source><award-id>109008/Z/15/A</award-id></award-group></funding-group><counts><fig-count count="1"/><table-count count="2"/><page-count count="5"/><word-count count="3095"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>December 2019</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.5 mode:remove_FC converted:21.01.2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body id="cytoa23907-body-0001"><sec id="cytoa23907-sec-0001"><title>Purpose and Sample Types</title><p>This 14&#8208;color, 16&#8208;antibody OMIP was designed for enumeration of leukocyte responses in pediatric samples, where sample volumes and cell numbers can be very low. Leukocytes identified by this panel include all major members of the innate lymphoid cell (ILC) family (ILC1s, ILC2s, and ILC3s), natural killer cells (NK cells), granulocytes (neutrophils and eosinophils), T&#8208;cells (CD4<sup>+</sup> and CD8<sup>+</sup>), mucosal&#8208;associated invariant T cells (MAIT cells) and NKT&#8208;like cells. The protocol was optimized using small volumes of peripheral blood and validated in airway samples obtained from children (&lt;&#8201;2&#8201;years of age) admitted to a pediatric intensive care unit (PICU). Given this backdrop, this OMIP is widely applicable to clinical research using low volume or paucicellular samples, such as studies of innate and adaptive immune responses in infants and children, with potential clinical application in diagnostics and monitoring of patients by pediatricians.</p></sec><sec id="cytoa23907-sec-0002"><title>Background</title><p>The immaturity of the immune system in early life renders infants vulnerable to infectious diseases, particularly those of the gastrointestinal and respiratory tracts. According to the World Health Organization, acute lower respiratory tract infections are the leading cause of death and hospitalization in children globally <xref rid="cytoa23907-bib-0001" ref-type="ref">1</xref>. How the immune system matures in early life is not fully understood. A better understanding of the nature of the immune and inflammatory response to infection in infants and why some infants develop disease could help to identify new clinical biomarkers, treatments, and prophylactics.</p><p>One of the major hurdles in the field of neonatal and pediatric immunology is obtaining relevant samples, which is limited by ethical restrictions on the volume and number of samples that can be taken. As a result, much of our understanding of cellular immunity in infants comes from studies of umbilical cord blood. Less is known about immunity in more mature infants, and less still is known about immunity to infection at mucosal sites, such as the lung <xref rid="cytoa23907-bib-0002" ref-type="ref">2</xref>, <xref rid="cytoa23907-bib-0003" ref-type="ref">3</xref>, <xref rid="cytoa23907-bib-0004" ref-type="ref">4</xref>. Moreover, the use of invasive procedures to obtain, for example, lower airway samples cannot be justified in healthy infants. It is important, therefore, that techniques are developed that facilitate the characterization of the immune response in small&#8208;volume and paucicellular samples, particularly from sites of infection where sampling is limited. In designing this OMIP <xref rid="cytoa23907-bib-0005" ref-type="ref">5</xref> we focused on developing a panel to enumerate the innate lymphoid cell (ILC), granulocyte and T&#8208;cell responses in infants, particularly those with a lung infection (Table <xref rid="cytoa23907-tbl-0001" ref-type="table">1</xref>). To reflect the challenging situation of limited amounts of blood and airway samples from infants we optimized this panel using a small volume (300&#8201;&#956;l) of adult peripheral blood. Pitoiset et al. (2018) were able to detect regulatory T cells (Tregs) in as little as 60&#8201;&#956;l of whole blood from children <xref rid="cytoa23907-bib-0006" ref-type="ref">6</xref> and others have demonstrated the feasibility of detecting T cell subsets and Type 2 ILCs within pediatric airway samples <xref rid="cytoa23907-bib-0007" ref-type="ref">7</xref>, <xref rid="cytoa23907-bib-0008" ref-type="ref">8</xref>.</p><table-wrap id="cytoa23907-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>Summary table</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th><th align="left" valign="bottom" rowspan="1" colspan="1">Myeloid and innate/adaptive lymphoid comprehensive immunophenotyping</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell types</td><td align="left" valign="top" rowspan="1" colspan="1">Whole peripheral blood, cord blood, PBMCs, nasal aspirate, and tracheal aspirate samples</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Species</td><td align="left" valign="top" rowspan="1" colspan="1">Human</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cross&#8208;reference</td><td align="left" valign="top" rowspan="1" colspan="1">OMIP&#8208;55, OMIP&#8208;007, OMIP&#8208;27, OMIP&#8208;029, OMIP&#8208;038, OMIP&#8208;039</td></tr></tbody></table></table-wrap><p>The recently discovered ILCs have been implicated in playing a pivotal role in immune responses to viral and bacterial pathogens, and they are particularly abundant at mucosal sites <xref rid="cytoa23907-bib-0009" ref-type="ref">9</xref>, <xref rid="cytoa23907-bib-0010" ref-type="ref">10</xref>, <xref rid="cytoa23907-bib-0011" ref-type="ref">11</xref>. There are three main subsets of ILC; ILC1s, ILC2s, and ILC3s, which may mirror CD4<sup>+</sup> T helper 1 (Th1), Th2, and Th17 subsets, whereas NK cells may complement the cytokine profile and function of CD8<sup>+</sup> T cells <xref rid="cytoa23907-bib-0012" ref-type="ref">12</xref>. ILCs comprise only 0.1 to 0.01% of lymphocytes in adult blood <xref rid="cytoa23907-bib-0013" ref-type="ref">13</xref> and most published methods for detection of ILCs are optimized on relatively large volumes of peripheral blood, however, since ILCs are relatively abundant in children we anticipated relatively high frequencies in small volume pediatric samples <xref rid="cytoa23907-bib-0008" ref-type="ref">8</xref>, <xref rid="cytoa23907-bib-0014" ref-type="ref">14</xref>, <xref rid="cytoa23907-bib-0015" ref-type="ref">15</xref>. Immunophenotyping ILCs can be challenging as they are defined as lineage negative lymphocytes, which lack specific markers, including CD3 (T cells), CD19 (B cells), CD34 (progenitor cells), Fc&#949;R1&#945; (mast cells) and CD1a, CD123, BDCA2 (plasmacytoid dendritic cells, pDC) <xref rid="cytoa23907-bib-0015" ref-type="ref">15</xref>, <xref rid="cytoa23907-bib-0016" ref-type="ref">16</xref>. Accordingly, while designing this panel we made sure that a very stringent gating strategy was utilized to obtain a pure ILC subset. We used biaxial gating to delineate ILCs as lineage negative, CD127 (IL&#8208;7 receptor&#8208;&#945;) positive, live lymphocytes. We distinguished ILC subsets using surface expression of prostaglandin D<sub>2</sub> receptor chemoattractant receptor&#8208;homologous molecule expressed on Th2 cells (CRTH2) and CD117 (c&#8208;Kit) <xref rid="cytoa23907-bib-0008" ref-type="ref">8</xref>, <xref rid="cytoa23907-bib-0010" ref-type="ref">10</xref>, <xref rid="cytoa23907-bib-0017" ref-type="ref">17</xref>. In designing this OMIP other components of the cellular immune response were included, which gives this panel broad applicability to other pediatric clinical studies. These were myeloid cells (neutrophils, eosinophils), invariant T cells (mucosal invariant T cells (MAITs) and NKT&#8208;like cells) and adaptive T cells (CD4<sup>+</sup> and CD8<sup>+</sup>). By immunophenotyping whole blood, rather than peripheral blood mononuclear cells (PBMC), we reduced the processing time and retained granulocyte populations. All fluorochrome&#8208;conjugated antibodies were titrated during panel optimization and are listed in Table <xref rid="cytoa23907-tbl-0002" ref-type="table">2</xref>.</p><table-wrap id="cytoa23907-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Antibodies used in the optimized multicolor immunofluorescence panel (OMIP&#8208;062)</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Antibody</th><th align="left" valign="bottom" rowspan="1" colspan="1">Fluorochrome</th><th align="left" valign="bottom" rowspan="1" colspan="1">Ab Clone</th><th align="left" valign="bottom" rowspan="1" colspan="1">Purpose</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">CD127 (IL&#8208;7R&#945;)</td><td align="left" valign="top" rowspan="1" colspan="1">BV421</td><td align="left" valign="top" rowspan="1" colspan="1">A019D5</td><td align="left" valign="top" rowspan="1" colspan="1">ILCs</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD14<xref ref-type="fn" rid="cytoa23907-note-0001">a</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">BV510</td><td align="left" valign="top" rowspan="1" colspan="1">63D3</td><td align="left" valign="top" rowspan="1" colspan="1">Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD19<xref ref-type="fn" rid="cytoa23907-note-0001">a</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">BV510</td><td align="left" valign="top" rowspan="1" colspan="1">HIB19</td><td align="left" valign="top" rowspan="1" colspan="1">Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fc&#949;RI&#945;<xref ref-type="fn" rid="cytoa23907-note-0001">a</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">BV510</td><td align="left" valign="top" rowspan="1" colspan="1">AER&#8208;37 (CRA&#8208;1)</td><td align="left" valign="top" rowspan="1" colspan="1">Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD123<xref ref-type="fn" rid="cytoa23907-note-0001">a</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">BV510</td><td align="left" valign="top" rowspan="1" colspan="1">6H6</td><td align="left" valign="top" rowspan="1" colspan="1">Lineage</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD4</td><td align="left" valign="top" rowspan="1" colspan="1">BV605</td><td align="left" valign="top" rowspan="1" colspan="1">RPA&#8208;T4</td><td align="left" valign="top" rowspan="1" colspan="1">CD4<sup>+</sup> T cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD16</td><td align="left" valign="top" rowspan="1" colspan="1">BV650</td><td align="left" valign="top" rowspan="1" colspan="1">3G8</td><td align="left" valign="top" rowspan="1" colspan="1">NK cells/neutrophils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD8</td><td align="left" valign="top" rowspan="1" colspan="1">BV711</td><td align="left" valign="top" rowspan="1" colspan="1">SK1</td><td align="left" valign="top" rowspan="1" colspan="1">CD8<sup>+</sup> T cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">TCR V&#945;7.2</td><td align="left" valign="top" rowspan="1" colspan="1">BV785</td><td align="left" valign="top" rowspan="1" colspan="1">3C10</td><td align="left" valign="top" rowspan="1" colspan="1">MAIT cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD45</td><td align="left" valign="top" rowspan="1" colspan="1">FITC</td><td align="left" valign="top" rowspan="1" colspan="1">HI30</td><td align="left" valign="top" rowspan="1" colspan="1">Leukocytes</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD117 (c&#8208;kit)</td><td align="left" valign="top" rowspan="1" colspan="1">PerCP&#8208;Cy5.5</td><td align="left" valign="top" rowspan="1" colspan="1">A3C6E2</td><td align="left" valign="top" rowspan="1" colspan="1">ILC3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD3<xref ref-type="fn" rid="cytoa23907-note-0002">b</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">PE</td><td align="left" valign="top" rowspan="1" colspan="1">OKT3</td><td align="left" valign="top" rowspan="1" colspan="1">T cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD161</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Dazzle</td><td align="left" valign="top" rowspan="1" colspan="1">HP&#8208;3G10</td><td align="left" valign="top" rowspan="1" colspan="1">MAIT cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD56 (NCAM)<xref ref-type="fn" rid="cytoa23907-note-0002">b</xref>
</td><td align="left" valign="top" rowspan="1" colspan="1">PE&#8208;Cy7</td><td align="left" valign="top" rowspan="1" colspan="1">5.1H11</td><td align="left" valign="top" rowspan="1" colspan="1">NK/NKT&#8208;like cells</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD294 (CRTH2)</td><td align="left" valign="top" rowspan="1" colspan="1">AF647</td><td align="left" valign="top" rowspan="1" colspan="1">BM16</td><td align="left" valign="top" rowspan="1" colspan="1">ILC2/Th2/Tc2 subsets</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CD66b</td><td align="left" valign="top" rowspan="1" colspan="1">AF700</td><td align="left" valign="top" rowspan="1" colspan="1">G10F5</td><td align="left" valign="top" rowspan="1" colspan="1">Eosinophils</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Live/Dead</td><td align="left" valign="top" rowspan="1" colspan="1">Near IR&#8208;fluorescent reactive dye</td><td align="left" valign="top" rowspan="1" colspan="1">n/a</td><td align="left" valign="top" rowspan="1" colspan="1">Viability</td></tr></tbody></table><table-wrap-foot id="cytoa23907-ntgp-0001"><fn id="cytoa23907-note-0001"><label>a</label><p>Lineage cocktail includes the following antibodies: CD14, CD19, CD123, Fc&#949;R1&#945;.</p></fn><fn id="cytoa23907-note-0002"><label>b</label><p>Antibodies used to define the lineage negative population, but not part of the lineage cocktail.</p></fn></table-wrap-foot></table-wrap><p>Cells were delineated using the following gating strategy: FSC/SSC, single cells, live cells. Granulocytes, monocytes, and lymphocytes were gated using FSC and the CD45 cell marker (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>A). Within the granulocyte population, neutrophils were defined as CD16<sup>H</sup>CD66b<sup>+/&#8722;</sup> and eosinophils as CD16<sup>+/&#8208;</sup>CD66b<sup>+</sup> (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>B). Within the lymphocyte gate, the markers CD56 and CD3 were used to identify NK cells (CD56<sup>+</sup>CD3<sup>&#8722;</sup>), conventional T lymphocytes (CD3<sup>+</sup>CD56<sup>&#8722;</sup>) and NKT&#8208;like cells (CD56<sup>+</sup>CD3<sup>+</sup>) (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>D) <xref rid="cytoa23907-bib-0018" ref-type="ref">18</xref>, <xref rid="cytoa23907-bib-0019" ref-type="ref">19</xref>, <xref rid="cytoa23907-bib-0020" ref-type="ref">20</xref>. NK cells were further subdivided into CD56<sup>H</sup>CD16<sup>L</sup> and CD56<sup>L</sup>CD16<sup>H</sup> populations according to the CD56 and CD16 density (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>E). T lymphocytes (CD3<sup>+</sup>CD56<sup>&#8722;</sup>) were segregated into CD4<sup>+</sup> or CD8<sup>+</sup> T cells (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>H). Th2 and Tc2 cells were defined within the CD4<sup>+</sup> and CD8<sup>+</sup> T cell subsets, respectively, using the CRTH2 surface marker, as these Type&#8208;2 cytokine&#8208;producing cells express high levels of CRTH2 <xref rid="cytoa23907-bib-0008" ref-type="ref">8</xref>, <xref rid="cytoa23907-bib-0021" ref-type="ref">21</xref> (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>F,G). Within CD8<sup>+</sup> T cells, we also identified MAIT cells. MAIT cells are invariant T lymphocytes which respond to riboflavin metabolites in the context of the MHC class I related molecule MR1 <xref rid="cytoa23907-bib-0022" ref-type="ref">22</xref>, <xref rid="cytoa23907-bib-0023" ref-type="ref">23</xref>. MAIT cells were identified within the CD3<sup>+</sup>CD56<sup>&#8722;</sup>CD8<sup>+</sup> gate as CD161<sup>H</sup>V&#945;7.2<sup>+</sup>cells (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>I). NKT cells are conventionally described as CD3<sup>+</sup>CD56<sup>+</sup> lymphocytes <xref rid="cytoa23907-bib-0024" ref-type="ref">24</xref>, <xref rid="cytoa23907-bib-0025" ref-type="ref">25</xref>, however, the use of these markers alone defines a heterogeneous population of lymphocytes, which we designate here as &#8220;NKT&#8208;like&#8221; cells. CD56 can be expressed by many CD3<sup>+</sup> lymphocyte subpopulations, including invariant NKT cells (iNKT cells), and some &#947;&#948; T cells and MAIT cells (which have previously been described as mucosal NKT cells) <xref rid="cytoa23907-bib-0026" ref-type="ref">26</xref>, <xref rid="cytoa23907-bib-0027" ref-type="ref">27</xref>. Strategies to define these subpopulations are discussed further in the Supporting Information (<xref rid="cytoa23907-supitem-0001" ref-type="supplementary-material">Part B</xref>). Finally, ILCs were defined using the following gating strategy: live, single, CD45<sup>+</sup> lymphocytes, lineage (CD3, CD56, CD14, CD19, CD123, Fc&#949;R1&#945;) negative, and CD127<sup>+</sup> cells (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>C); ILC1s were defined as CD117<sup>&#8722;</sup>CRTH2<sup>&#8722;</sup>, ILC2s as CRTH2<sup>+</sup> CD117<sup>int</sup>, and ILC3s as CD117<sup>+</sup>CRTH2<sup>&#8722;</sup>
<xref rid="cytoa23907-bib-0015" ref-type="ref">15</xref>, <xref rid="cytoa23907-bib-0028" ref-type="ref">28</xref>.</p><fig fig-type="Figure" xml:lang="en" id="cytoa23907-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Example gating strategy and t&#8208;SNE analysis for visualization of ILCs (including NK cells), granulocytes, MAIT, NKT&#8208;like cells, and other T cell populations in pediatric clinical samples. Abbreviations: B, counting beads; L&#8201;+&#8201;G, lymphocyte and granulocyte gate; LD, live/dead; GRAN, granulocytes; MON, monocytes; LYM, lymphocytes; NEU, neutrophils; EOS, eosinophils; ILC, innate lymphoid cells; MAIT, mucosal&#8208;associated invariant T cells; NK, natural killer cells; NKT&#8208;like, natural killer T like cells; ?, Unidentified populations. [Color figure can be viewed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com">http://wileyonlinelibrary.com</ext-link>]</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="nlm-graphic-1" position="float" orientation="portrait" xlink:href="CYTO-95-1231-g001.jpg"/></fig><p>To further analyze different populations of cells in this OMIP, unbiased high dimensional stoichiometry (t&#8208;SNE) analysis was performed on live, single, CD45<sup>+</sup> cells incorporating the lymphocyte, granulocyte, and monocyte gates (Fig. <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>J). In this example, t&#8208;SNE not only revealed that all the populations of cells segregated according to the gating strategy illustrated in Figure <xref rid="cytoa23907-fig-0001" ref-type="fig">1</xref>A&#8211;I but additionally discriminated distinct or poorly defined populations. Therefore, this 14&#8208;color flow panel can be used to delineate other unknown populations using high&#8208;dimensional data visualization techniques <xref rid="cytoa23907-bib-0029" ref-type="ref">29</xref>.</p><p>Following optimization on adult peripheral blood, we confirmed that the panel was suitable for staining umbilical cord blood, and peripheral blood, tracheal aspirate, and nasal aspirate samples from infants. The inclusion of CD45 in the panel allowed us to separate leukocytes from structural cells, such as epithelial cells, found in airway samples. Concentrations of antibodies were kept the same for analysis of different samples as they gave the same optimal separation between positive and negative populations; however, the protocol for staining airway samples was more methodically complicated and included the use of Fc block. Counting beads were included to allow absolute counts of cell numbers. Detailed information on the panel development and optimization can be found in the Supporting Information (<xref rid="cytoa23907-supitem-0001" ref-type="supplementary-material">Part B</xref>).</p></sec><sec id="cytoa23907-sec-0003"><title>Human Samples</title><p>All blood and airway samples were collected from subjects after gaining written consent. Some samples were collected as a part of the Early Life Lung Infection (ELLI) and RSV&#8208;SAM studies, at St. Mary's Hospital, London. The use of all human tissue samples was approved by the Health Research Authority (HRA) and Health and Care Research Wales (HCRW) Ethics Committee (REC numbers 18/LO/1570; 15/WM/0343 and 13/LO/1712) and in accordance with the Declaration of Helsinki 1964.</p></sec><sec id="cytoa23907-sec-0004"><title>Similarity to Other OMIPs</title><p>OMIP&#8208;55 cross&#8208;references to the ILC immunophenotyping; OMIP&#8208;007, OMIP&#8208;027, and OMIP&#8208;029, OMIP&#8208;38 and OMIP&#8208;039 include phenotypic analysis of NK cells.</p></sec><sec sec-type="COI-statement" id="cytoa23907-sec-0005"><title>Conflict of interest</title><p>The authors have no conflicts of interest to declare.</p></sec><sec id="cytoa23907-sec-0007"><title>Funding</title><p>Research Support: Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London; Grant number: AUK&#8208;BC&#8208;2015&#8208;01; National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London; Grant numbers: RDA02 and P82570, The Wellcome Trust; Grant number: 109008/Z/15/A.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data" id="cytoa23907-supitem-0001" position="float" orientation="portrait"><caption><p>
<bold>Appendix S1</bold>: Supporting Information</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-95-1231-s001.docx" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="cytoa23907-supitem-0002" position="float" orientation="portrait"><caption><p>
<bold>MIFlowCyt</bold>: MIFlowCyt&#8208;Compliant Items</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="CYTO-95-1231-s002.doc" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="cytoa23907-sec-0006"><title>Acknowledgments</title><p>We thank the St. Mary's Flow Cytometry Core Facility for support and instrumentation during the design of this panel. We are particularly thankful to Prof Beate Kampmann, Dr Beth Holder, Dr Tom Rice, and Sara Barnett for providing cord blood samples. We would like to thank Prof Trevor Hansel for valuable discussions. Finally, we are grateful to research nurses Sarah Darnell, Sobia Mustafa, Ladan Ali, Amina Abdulla, and Suzanne Laing for collecting pediatric samples. This article is independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health.</p></ack><ref-list id="cytoa23907-bibl-0001" content-type="cited-references"><title>Literature Cited</title><ref id="cytoa23907-bib-0001"><label>1</label><mixed-citation publication-type="miscellaneous" id="cytoa23907-cit-0001"><collab collab-type="authors">WHO</collab>
. <article-title>WHO Consultation on respiratory syncytial virus (RSV) vaccine development</article-title><year>2015</year>.</mixed-citation></ref><ref id="cytoa23907-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0002"><string-name name-style="western"><surname>Adkins</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Leclerc</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Marshall&#8208;Clarke</surname><given-names>S</given-names></string-name>. <article-title>Neonatal adaptive immunity comes of age</article-title>. <source xml:lang="en">Nat Rev Immunol</source><year>2004</year>;<volume>4</volume>:<fpage>553</fpage>&#8211;<lpage>564</lpage>.<pub-id pub-id-type="pmid">15229474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri1394</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0003"><string-name name-style="western"><surname>Lambert</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Sagfors</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Openshaw</surname><given-names>PJM</given-names></string-name>, <string-name name-style="western"><surname>Culley</surname><given-names>FJ</given-names></string-name>. <article-title>Immunity to RSV in early life</article-title>. <source xml:lang="en">Front Immunol</source><year>2014</year>;<volume>5</volume>:<fpage>1</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="pmid">25324843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2014.00466</pub-id><pub-id pub-id-type="pmcid">PMC4179512</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0004"><string-name name-style="western"><surname>Yu</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Khodadadi</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Malik</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Davidson</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Salles</surname><given-names>&#201;DSL</given-names></string-name>, <string-name name-style="western"><surname>Bhatia</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Hale</surname><given-names>VL</given-names></string-name>, <string-name name-style="western"><surname>Baban</surname><given-names>B</given-names></string-name>. <article-title>Innate immunity of neonates and infants</article-title>. <source xml:lang="en">Front Immunol</source><year>2018</year>;<volume>9</volume>:<fpage>1759</fpage>.<pub-id pub-id-type="pmid">30105028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2018.01759</pub-id><pub-id pub-id-type="pmcid">PMC6077196</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0005"><string-name name-style="western"><surname>Mahnke</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Chattopadhyay</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>. <article-title>Publication of optimized multicolor immunofluorescence panels</article-title>. <source xml:lang="en">Cytom Part A</source><year>2010</year>;<volume>77</volume>:<fpage>814</fpage>&#8211;<lpage>818</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.20916</pub-id><pub-id pub-id-type="pmid">20722004</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0006"><string-name name-style="western"><surname>Pitoiset</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Barbi&#233;</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Monneret</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Braudeau</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pochard</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Pellegrin</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Trauet</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Labalette</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Klatzmann</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rosenzwajg</surname><given-names>M</given-names></string-name>. <article-title>A standardized flow cytometry procedure for the monitoring of regulatory T cells in clinical trials</article-title>. <source xml:lang="en">Cytom Part B</source><year>2018</year>;<volume>94</volume>:<fpage>777</fpage>&#8211;<lpage>782</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.b.21622</pub-id><pub-id pub-id-type="pmid">29316248</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0007"><string-name name-style="western"><surname>Connors</surname><given-names>TJ</given-names></string-name>, <string-name name-style="western"><surname>Baird</surname><given-names>JS</given-names></string-name>, <string-name name-style="western"><surname>Yopes</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Zens</surname><given-names>KD</given-names></string-name>, <string-name name-style="western"><surname>Pethe</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Ravindranath</surname><given-names>TM</given-names></string-name>, et al. <article-title>Developmental regulation of effector and resident memory T cell generation during pediatric viral respiratory tract infection</article-title>. <source xml:lang="en">J Immunol</source><year>2018</year>;<volume>201</volume>(<issue>2</issue>):<fpage>432</fpage>&#8211;<lpage>439</lpage>.<pub-id pub-id-type="pmid">29848753</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1800396</pub-id><pub-id pub-id-type="pmcid">PMC6039242</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0008"><string-name name-style="western"><surname>Nagakumar</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Denney</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Fleming</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Bush</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Lloyd</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Saglani</surname><given-names>S</given-names></string-name>. <article-title>Type 2 innate lymphoid cells in induced sputum from children with severe asthma</article-title>. <source xml:lang="en">J Allergy Clin Immunol</source><year>2016</year>;<volume>137</volume>:<fpage>624</fpage>&#8211;<lpage>626</lpage>.<pub-id pub-id-type="pmid">26277593</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2015.06.038</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0009"><string-name name-style="western"><surname>Bernink</surname><given-names>JH</given-names></string-name>, <string-name name-style="western"><surname>Peters</surname><given-names>CP</given-names></string-name>, <string-name name-style="western"><surname>Munneke</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Te Velde</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Meijer</surname><given-names>SL</given-names></string-name>, <string-name name-style="western"><surname>Weijer</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Hreggvidsdottir</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Heinsbroek</surname><given-names>SE</given-names></string-name>, <string-name name-style="western"><surname>Legrand</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Buskens</surname><given-names>CJ</given-names></string-name>, et al. <article-title>Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues</article-title>. <source xml:lang="en">Nat Immunol</source><year>2013</year>;<volume>14</volume>:<fpage>221</fpage>&#8211;<lpage>229</lpage>.<pub-id pub-id-type="pmid">23334791</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.2534</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0010"><string-name name-style="western"><surname>Dhariwal</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cameron</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Trujillo&#8208;Torralbo</surname><given-names>M&#8208;B</given-names></string-name>, <string-name name-style="western"><surname>del Rosario</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Bakhsoliani</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Paulsen</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Jackson</surname><given-names>DJ</given-names></string-name>, <string-name name-style="western"><surname>Edwards</surname><given-names>MR</given-names></string-name>, <string-name name-style="western"><surname>BMJ</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Cousins</surname><given-names>DJ</given-names></string-name>, et al. <article-title>Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens</article-title>. <source xml:lang="en">Am J Respir Crit Care Med</source><year>2017</year>;<volume>195</volume>:<fpage>1586</fpage>&#8211;<lpage>1596</lpage>.<pub-id pub-id-type="pmid">28085492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1164/rccm.201609-1846OC</pub-id><pub-id pub-id-type="pmcid">PMC5476911</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0011"><string-name name-style="western"><surname>Elemam</surname><given-names>NM</given-names></string-name>, <string-name name-style="western"><surname>Hannawi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Maghazachi</surname><given-names>AA</given-names></string-name>. <article-title>Innate lymphoid cells (ILCs) as mediators of inflammation, release of cytokines and lytic molecules</article-title>. <source xml:lang="en">Toxins (Basel)</source><year>2017</year>;<volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>18</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/toxins9120398</pub-id><pub-id pub-id-type="pmcid">PMC5744118</pub-id><pub-id pub-id-type="pmid">29232860</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0012"><string-name name-style="western"><surname>Ebbo</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Crinier</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>V&#233;ly</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Vivier</surname><given-names>E</given-names></string-name>. <article-title>Innate lymphoid cells: Major players in inflammatory diseases</article-title>. <source xml:lang="en">Nat Rev Immunol</source><year>2017</year>;<volume>17</volume>:<fpage>665</fpage>&#8211;<lpage>678</lpage>.<pub-id pub-id-type="pmid">28804130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri.2017.86</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0013"><string-name name-style="western"><surname>Hazenberg</surname><given-names>MD</given-names></string-name>, <string-name name-style="western"><surname>Spits</surname><given-names>H</given-names></string-name>. <article-title>Human innate lymphoid cells</article-title>. <source xml:lang="en">Blood</source><year>2014</year>;<volume>124</volume>:<fpage>700</fpage>&#8211;<lpage>710</lpage>.<pub-id pub-id-type="pmid">24778151</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2013-11-427781</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0014"><string-name name-style="western"><surname>Bj&#246;rklund</surname><given-names>&#197;K</given-names></string-name>, <string-name name-style="western"><surname>Forkel</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Picelli</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Konya</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Theorell</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Friberg</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sandberg</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Mj&#246;sberg</surname><given-names>J</given-names></string-name>. <article-title>The heterogeneity of human CD127+ innate lymphoid cells revealed by single&#8208;cell RNA sequencing</article-title>. <source xml:lang="en">Nat Immunol</source><year>2016</year>;<volume>17</volume>:<fpage>451</fpage>&#8211;<lpage>460</lpage>.<pub-id pub-id-type="pmid">26878113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3368</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0015"><string-name name-style="western"><surname>V&#233;ly</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Barlogis</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Vallentin</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Neven</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Piperoglou</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Ebbo</surname><given-names>M</given-names></string-name>, et al. <article-title>Evidence of innate lymphoid cell redundancy in humans</article-title>. <source xml:lang="en">Nat Immunol</source><year>2016</year>;<volume>17</volume>:<fpage>1291</fpage>&#8211;<lpage>1299</lpage>.<pub-id pub-id-type="pmid">27618553</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3553</pub-id><pub-id pub-id-type="pmcid">PMC5074366</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0016"><string-name name-style="western"><surname>Simoni</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Fehlings</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Kl&#248;verpris</surname><given-names>HN</given-names></string-name>, <string-name name-style="western"><surname>Tan</surname><given-names>IB</given-names></string-name>, <string-name name-style="western"><surname>Ginhoux</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Newell</surname><given-names>EW</given-names></string-name>. <article-title>Human innate lymphoid cell subsets possess human innate lymphoid cell subsets possess tissue&#8208;type based heterogeneity in phenotype and frequency</article-title>. <source xml:lang="en">Immunity</source><year>2017</year>;<volume>46</volume>:<fpage>148</fpage>&#8211;<lpage>161</lpage>.<pub-id pub-id-type="pmid">27986455</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2016.11.005</pub-id><pub-id pub-id-type="pmcid">PMC7612935</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0017"><string-name name-style="western"><surname>Wallrapp</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Riesenfeld</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Burkett</surname><given-names>PR</given-names></string-name>, <string-name name-style="western"><surname>Abdulnour</surname><given-names>R&#8208;EE</given-names></string-name>, <string-name name-style="western"><surname>Nyman</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Dionne</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Hofree</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Cuoco</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Rodman</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Farouq</surname><given-names>D</given-names></string-name>, et al. <article-title>The neuropeptide NMU amplifies ILC2&#8208;driven allergic lung inflammation</article-title>. <source xml:lang="en">Nature</source><year>2017</year>;<volume>549</volume>:<fpage>351</fpage>&#8211;<lpage>356</lpage>.<pub-id pub-id-type="pmid">28902842</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature24029</pub-id><pub-id pub-id-type="pmcid">PMC5746044</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0018"><string-name name-style="western"><surname>Costanzo</surname><given-names>MC</given-names></string-name>, <string-name name-style="western"><surname>Creegan</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Lal</surname><given-names>KG</given-names></string-name>, <string-name name-style="western"><surname>Eller</surname><given-names>MA</given-names></string-name>. <article-title>OMIP&#8208;027: Functional analysis of human natural killer cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2015</year>;<volume>87</volume>:<fpage>803</fpage>&#8211;<lpage>805</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22719</pub-id><pub-id pub-id-type="pmid">26189970</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0019"><string-name name-style="western"><surname>Mahnke</surname><given-names>YD</given-names></string-name>, <string-name name-style="western"><surname>Beddall</surname><given-names>MH</given-names></string-name>, <string-name name-style="western"><surname>Roederer</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;029: Human NK&#8208;cell phenotypization</article-title>. <source xml:lang="en">Cytom Part A</source><year>2015</year>;<volume>87</volume>:<fpage>986</fpage>&#8211;<lpage>988</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22728</pub-id><pub-id pub-id-type="pmid">26228006</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0020"><string-name name-style="western"><surname>Eller</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Currier</surname><given-names>JR</given-names></string-name>. <article-title>OMIP&#8208;007: Phenotypic analysis of human natural killer cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2012</year>;<volume>81A</volume>:<fpage>447</fpage>&#8211;<lpage>449</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.22033</pub-id><pub-id pub-id-type="pmid">22411905</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0021"><string-name name-style="western"><surname>Hilvering</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Hinks</surname><given-names>TSC</given-names></string-name>, <string-name name-style="western"><surname>St&#246;ger</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Marchi</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Salimi</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Shrimanker</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Go</surname><given-names>S</given-names></string-name>, et al. <article-title>Synergistic activation of pro&#8208;inflammatory type&#8208;2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma</article-title>. <source xml:lang="en">Mucosal Immunol</source><year>2018</year>;<volume>11</volume>:<fpage>1408</fpage>&#8211;<lpage>1419</lpage>.<pub-id pub-id-type="pmid">29907870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41385-018-0049-9</pub-id><pub-id pub-id-type="pmcid">PMC6448764</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0022"><string-name name-style="western"><surname>Wang</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Hogquist</surname><given-names>KA</given-names></string-name>. <article-title>How MAIT cells get their start</article-title>. <source xml:lang="en">Nat Immunol</source><year>2016</year>;<volume>17</volume>:<fpage>1238</fpage>&#8211;<lpage>1240</lpage>.<pub-id pub-id-type="pmid">27760106</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ni.3584</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0023"><string-name name-style="western"><surname>Godfrey</surname><given-names>DI</given-names></string-name>, <string-name name-style="western"><surname>Koay</surname><given-names>HF</given-names></string-name>, <string-name name-style="western"><surname>McCluskey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Gherardin</surname><given-names>NA</given-names></string-name>. <article-title>The biology and functional importance of MAIT cells</article-title>. <source xml:lang="en">Nat Immunol</source><year>2019</year>;<volume>20</volume>:<fpage>1110</fpage>&#8211;<lpage>1128</lpage>.<pub-id pub-id-type="pmid">31406380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-019-0444-8</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0024"><string-name name-style="western"><surname>Peng</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Mao</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>WH</given-names></string-name>, <string-name name-style="western"><surname>Lv</surname><given-names>YP</given-names></string-name>, <string-name name-style="western"><surname>Teng</surname><given-names>YS</given-names></string-name>, et al. <article-title>Altered phenotypic and functional characteristics of CD3+CD56+ NKT&#8208;like cells in human gastric cancer</article-title>. <source xml:lang="en">Oncotarget</source><year>2016</year>;<volume>7</volume>:<fpage>55222</fpage>&#8211;<lpage>55230</lpage>.<pub-id pub-id-type="pmid">27409423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18632/oncotarget.10484</pub-id><pub-id pub-id-type="pmcid">PMC5342413</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0025"><string-name name-style="western"><surname>Hammer</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Romagnani</surname><given-names>C</given-names></string-name>. <article-title>OMIP&#8208;039: Detection and analysis of human adaptive NKG2C + natural killer cells</article-title>. <source xml:lang="en">Cytom Part A</source><year>2017</year>;<volume>91</volume>:<fpage>997</fpage>&#8211;<lpage>1000</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23168</pub-id><pub-id pub-id-type="pmid">28715616</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0026"><string-name name-style="western"><surname>Van Acker</surname><given-names>HH</given-names></string-name>, <string-name name-style="western"><surname>Capsomidis</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Smits</surname><given-names>EL</given-names></string-name>, <string-name name-style="western"><surname>Van Tendeloo</surname><given-names>VF</given-names></string-name>. <article-title>CD56 in the immune system: More than a marker for cytotoxicity?</article-title><source xml:lang="en">Front Immunol</source><year>2017</year>;<volume>8</volume>:<fpage>892</fpage>.<pub-id pub-id-type="pmid">28791027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2017.00892</pub-id><pub-id pub-id-type="pmcid">PMC5522883</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0027"><string-name name-style="western"><surname>Wingender</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Kronenberg</surname><given-names>M</given-names></string-name>. <article-title>Role of NKT cells in the digestive system. IV. The role of canonical natural killer T cells in mucosal immunity and inflammation</article-title>. <source xml:lang="en">Am J Physiol Liver Physiol</source><year>2007</year>;<volume>294</volume>:<fpage>G1</fpage>&#8211;<lpage>G8</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpgi.00437.2007</pub-id><pub-id pub-id-type="pmid">17947447</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0028"><string-name name-style="western"><surname>Bianca Bennstein</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Riccarda Manser</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Weinhold</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Scherenschlich</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Uhrberg</surname><given-names>M</given-names></string-name>. <article-title>OMIP&#8208;055: Characterization of human innate lymphoid cells from neonatal and peripheral blood</article-title>. <source xml:lang="en">Cytom Part A</source><year>2019</year>;<volume>95</volume>:<fpage>427</fpage>&#8211;<lpage>430</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cyto.a.23741</pub-id><pub-id pub-id-type="pmid">30887685</pub-id></mixed-citation></ref><ref id="cytoa23907-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cytoa23907-cit-0029"><string-name name-style="western"><surname>Van der Maaten</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Hinton</surname><given-names>G</given-names></string-name>. <article-title>Visualizing Data using t&#8208;SNE</article-title>. <source xml:lang="en">J Mach Learn Res</source><year>2008</year>;<volume>9</volume>:<fpage>2579</fpage>&#8211;<lpage>2605</lpage>.</mixed-citation></ref></ref-list></back></article></pmc-articleset>